financetom
Business
financetom
/
Business
/
Nelson Peltz's Trian Fund trims stake in Unilever
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nelson Peltz's Trian Fund trims stake in Unilever
Aug 14, 2024 6:58 AM

By Yadarisa Shabong

(Reuters) - Nelson Peltz's Trian Fund Management has sold about 3.8 million shares in British consumer goods giant Unilever ( UL ) for nearly 181 million pounds ($232 million), a filing showed on Wednesday.

The fund, the No. 5 shareholder, had previously held a 1.47% stake, or 36.6 million shares, in the owner of Dove soap and Hellmann's mayonnaise worth about $1.8 billion, according to LSEG data.

It now holds about 32.6 million shares after the stake sale, a Trian spokesperson said in an emailed statement.

Peltz's hedge fund started building stake in Unilever ( UL ) in early 2022 and the activist investor joined the company's board in May that year.

As of Tuesday's close, Unilever ( UL ) shares have gained nearly 30% since Trian's stake was first made public in January 2022.

They have climbed more than 23% so far this year and had rallied last month after the company beat first-half profit expectations.

Trian had sold small stakes on Friday, Monday and Tuesday, according to the filing, for "portfolio management purposes".

Peltz had endorsed the appointment of Hein Schumacher as CEO in 2023. In his first year at the helm, Schumacher has overseen plans to spin off the company's ice cream business, lay off as many as 7,500 staff, and focus on 30 key brands to reverse years of underperformance.

Unilever ( UL ) shares were down marginally at 47.10 pounds at 1332 GMT.

Peltz looks forward to continuing to work with the company's board and management team, the spokesperson said.

($1 = 0.7785 pounds)

(Reporting by Yadarisa Shabong in Bengaluru and Agata Rybska in Gdansk; Editing by Sriraj Kalluvila)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Financial Crime Weekly: Cantor Fitzgerald Charged With Violating AntiFraud Provisions, Ex-ComTech CEO Charged With Insider Trading
Financial Crime Weekly: Cantor Fitzgerald Charged With Violating AntiFraud Provisions, Ex-ComTech CEO Charged With Insider Trading
Dec 14, 2024
SEC Charges Cantor Fitzgerald With Causing 2 SPACs To Make Misleading Statements The Securities and Exchange Commission on Thursday charged  financial services firm Cantor Fitzgerald, L.P. with causing two special purpose acquisition companies that it controlled to make misleading statements to investors ahead of their initial public offerings.  The SEC's Order states that a team of Cantor Fitzgerald executives controlled...
Iran currency slips to new lows amid U.S., Europe tensions
Iran currency slips to new lows amid U.S., Europe tensions
Dec 14, 2024
DUBAI (Reuters) - The Iranian currency extended its fall on Saturday, hitting a new all-time low against the U.S. dollar amid uncertainties about Donald Trump's imminent arrival in the White House and tensions with the West over Tehran's nuclear programme. The rial plunged to 756,000 to the dollar on the unofficial market on Saturday, compared to 741,500 rials on Friday,...
Trump taps Truth Social CEO Nunes to lead intelligence board
Trump taps Truth Social CEO Nunes to lead intelligence board
Dec 14, 2024
WASHINGTON, Dec 14 (Reuters) - U.S. President Donald Trump on Saturday named ally Devin Nunes, a former U.S. lawmaker who now runs Trump's Truth Social social media platform, to serve as chairman of President's Intelligence Advisory Board. Nunes, a longtime Trump defender who led the U.S. House of Representatives Intelligence Committee during part of Trump's first White House term, will...
Regulatory conditions on Novo Holdings' $16.5 billion Catalent deal fulfilled, companies say
Regulatory conditions on Novo Holdings' $16.5 billion Catalent deal fulfilled, companies say
Dec 14, 2024
(Reuters) - All regulatory closing conditions related to Novo Holdings' $16.5 billion acquisition of U.S. contract drug maker Catalent ( CTLT ) had been fulfilled, the companies said on Saturday, adding that the transaction is expected to be completed in the coming days. Novo Holdings in February agreed to buy Catalent ( CTLT ) to boost output of the popular...
Copyright 2023-2026 - www.financetom.com All Rights Reserved